BCM
OM icon

BML Capital Management’s Outset Medical OM Stock Holding History

BML Capital Management’s Portfolio OM Stock Details OM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$10.9M Buy
2,519,701
+617,500
+32% +$2.7M 6.18% 5
2026
Q1 		$7.3M Buy
1,902,201
+1,359,021
+250% +$5.57M 4.69% 5
2025
Q4 		$2.02M Buy
+543,180
New +$4.66M 1.74% 10

Other funds holding OM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.17B AUM 92.19% 1-Year Est. Return
Ensign Peak Advisors
Ensign Peak Advisors Salt Lake City, Utah $60.8B AUM 42.06% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.56% 1-Year Est. Return
PLC
Peapod Lane Capital Bedford Hills, New York $148M AUM 89.92% 1-Year Est. Return

BML Capital Management's OM Position: Q2 2026 in Review

BML Capital Management increased its Outset Medical (OM) stake by 32% in Q2 2026, buying an estimated $2.7M and bringing the position to 2,519,701 shares worth $10.9M. The position accounts for 6.18% of the portfolio, ranked #5.

BML Capital Management first reported a position in OM in Q4 2025 and has held it in 3 quarters since. 93 funds tracked by Wall St. Rank hold OM as of Q2 2026.

  • BML Capital Management held 2,519,701 shares of Outset Medical worth $10.9M as of Q2 2026.
  • BML Capital Management bought 617,500 Outset Medical shares in Q2 2026, an estimated $2.7M.
  • Outset Medical made up 6.18% of BML Capital Management's portfolio in Q2 2026, its #5 holding.
  • BML Capital Management first reported a position in Outset Medical in Q4 2025 and has held it in 3 quarters since.
  • 93 funds tracked by Wall St. Rank held Outset Medical as of Q2 2026.

Based on BML Capital Management's 13F filing for Q2 2026, filed 7 Aug 2026.